Please use this identifier to cite or link to this item:http://hdl.handle.net/20.500.12105/14316
Different HCV Exposure Drives Specific miRNA Profile in PBMCs of HIV Patients
Valle-Millares, Daniel ISCIII | Brochado-Kith, Oscar ISCIII | Martín-Carbonero, Luz | Domínguez-Domínguez, Lourdes | Ryan, Pablo | De Los Santos, Ignacio | De la Fuente, Sara | Castro, Juan M | Lagarde, María | Cuevas, Guillermo | Mayoral-Muñoz, Mario | Matarranz, Mariano | Díez, Victorino | Gomez-Sanz, Alicia ISCIII | Martinez-Roman, Paula ISCIII | Crespo-Bermejo, Celia ISCIII | Palladino, Claudia | Muñoz-Muñoz, María | Jimenez-Sousa, Maria Angeles ISCIII | Resino, Salvador ISCIII | Briz, Verónica ISCIII | Fernandez-Rodriguez, Amanda ISCIII | Multidisciplinary Group of Viral Coinfection HIV/Hepatitis (COVIHEP)
Biomedicines. 2021 Nov 5;9(11):1627.
Micro RNAs (miRNAs) are essential players in HIV and HCV infections, as both viruses modulate cellular miRNAs and interact with the miRNA-mediated host response. We aim to analyze the miRNA profile of HIV patients with different exposure to HCV to explore specific signatures in the miRNA profile of PBMCs for each type of infection. We massively sequenced small RNAs of PBMCs from 117 HIV+ infected patients: 45 HIV+ patients chronically infected with HCV (HIV/HCV+), 36 HIV+ that spontaneously clarified HCV after acute infection (HIV/HCV-) and 36 HIV+ patients without previous HCV infection (HIV). Thirty-two healthy patients were used as healthy controls (HC). Differential expression analysis showed significantly differentially expressed (SDE) miRNAs in HIV/HCV+ (n = 153), HIV/HCV- (n = 169) and HIV (n = 153) patients. We found putative dysregulated pathways, such as infectious-related and PI3K signaling pathways, common in all contrasts. Specifically, putatively targeted genes involved in antifolate resistance (HIV/HV+), cancer-related pathways (HIV/HCV-) and HIF-signaling (HIV) were identified, among others. Our findings revealed that HCV strongly influences the expression profile of PBMCs from HIV patients through the disruption of its miRNome. Thus, different HCV exposure can be identified by specific miRNA signatures in PBMCs.